VF
DRUG

Virtu Financial’s Bright Minds Biosciences DRUG Stock Holding History

Virtu Financial’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
3,129
+232
+8% +$18.7K 0.01% 958
2025
Q4 		$226K Buy
+2,897
New +$194K 0.01% 969
2024
Q1 		– Sell
-10,399
Closed -$15K – 1558
2023
Q4 		$15K Sell
10,399
-2,705
-21% -$3.86K ﹤0.01% 1359
2023
Q3 		$21K Buy
+13,104
New +$34.9K ﹤0.01% 1008
2023
Q1 		– Sell
-7,743
Closed -$29K – 1641
2022
Q4 		$29K Buy
+7,743
New +$38.3K ﹤0.01% 1186
2022
Q2 		– Sell
-2,912
Closed -$22K – 1691
2022
Q1 		$22K Buy
+2,912
New +$32.7K ﹤0.01% 1284

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Virtu Financial's DRUG Position: Q1 2026 in Review

Virtu Financial increased its Bright Minds Biosciences (DRUG) stake by 8% in Q1 2026, buying an estimated $18.7K and bringing the position to 3,129 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #958.

Virtu Financial first reported a position in DRUG in Q1 2022 and has held it in 6 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Virtu Financial held 3,129 shares of Bright Minds Biosciences worth $228K as of Q1 2026.
  • Virtu Financial bought 232 Bright Minds Biosciences shares in Q1 2026, an estimated $18.7K.
  • Bright Minds Biosciences made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #958 holding.
  • Virtu Financial first reported a position in Bright Minds Biosciences in Q1 2022 and has held it in 6 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.